scholarly journals Resource use and outcomes associated with initiation of injectable therapies for patients with type 2 diabetes mellitus

2015 ◽  
Vol 4 ◽  
pp. 1-14 ◽  
Author(s):  
Richard Brice ◽  
Sharon Shelley ◽  
Pankaj Chaturvedi ◽  
Divina Glah ◽  
Donna Ashley ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Resource Use

scholarly journals PDB24 REAL WORLD DATA ANALYSIS OF HEALTHCARE RESOURCE USE OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC KIDNEY DISEASE

2019 ◽  
Vol 22 ◽  
pp. S576
Author(s):  
D. Vivas Consuelo ◽  
S. González de Julián ◽  
J. Díaz-Carnicero ◽  
M.I. Saurí-Ferrer ◽  
R. Uso-Talamantes ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Chronic Kidney Disease ◽  
Type 2 Diabetes Mellitus ◽  
Data Analysis ◽  
Resource Use ◽  
Healthcare Resource ◽  
Healthcare Resource Use ◽  
Real World Data

scholarly journals Resource use and costs in patients with poorly controlled type 2 diabetes mellitus and obesity in routine clinical practice in Spain

2020 ◽  
Vol 36 (9) ◽  
pp. 1449-1456
Author(s):  
Silvia Díaz-Cerezo ◽  
Irene Romera ◽  
Antoni Sicras-Mainar ◽  
Flora López-Simarro ◽  
Tatiana Dilla ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Clinical Practice ◽  
Resource Use ◽  
Routine Clinical Practice

scholarly journals Cost Calculation for a Flash Glucose Monitoring System for Adults With Type 2 Diabetes Mellitus Using Intensive Insulin – a UK Perspective

2018 ◽  
Vol 14 (2) ◽  
pp. 86 ◽  
Author(s):  
Richard Hellmund ◽  
Raimund Weitgasser ◽  
Deirdre Blissett
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Resource Use ◽  
Healthcare Resource ◽  
Glucose Monitoring ◽  
Cost Calculation ◽  
Healthcare Resource Use ◽  
Flash Glucose Monitoring

Aims:Estimate the costs associated with flash glucose monitoring as a replacement for routine self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes mellitus (T2DM) using intensive insulin, from a UK National Health Service (NHS) perspective.Methods:The base-case cost calculation used the frequency of SMBG and healthcare resource use observed in the REPLACE trial. Scenario analyses considered SMBG at the flash monitoring frequencies observed in the REPLACE trial (8.3 tests per day) and a real-world analysis (16 tests per day).Results:Compared with 3 SMBG tests per day, flash monitoring would cost an additional £585 per patient per year, offset by a £776 reduction in healthcare resource use, based on reductions in emergency room visits (41%), ambulance call-outs (66%) and hospital admissions (77%) observed in the REPLACE trial. Per patient, the estimated total annual cost for flash monitoring was £191 (13.4%) lower than for SMBG. In the scenarios based on acquisition cost alone, flash monitoring was cost-neutral versus 8.3 SMBG tests per day (5% decrease) and cost-saving at higher testing frequencies.Conclusion:From a UK NHS perspective, for patients with T2DM using intensive insulin, flash monitoring is potentially cost-saving compared with routine SMBG irrespective of testing frequency. Keywords

Sign in / Sign up

Export Citation Format

Share Document